EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa ( PACT‐MEA ): Study design and rationale

Subodh Verma, Hani Sabbour, Naji Alamuddin, Fatheya Alawadi, Hessa Alkandari, Wael Almahmeed, Samir H Assaad-Khalil, Jihad Haddad, Landman Lombard, Rayaz A Malik iD, Emel Mashaki Ceyhan, Preethy Prasad und 2 weitere

Diabetes, Obesity and Metabolism · 2023

DOI: 10.1111/dom.15011 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2023. Verfasst von Subodh Verma und 13 weiteren Autor:innen. Beteiligte Einrichtung: St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Atherosclerosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate the epidemiology and clinical management of patients with type 2 diabetes (T2D) and established atherosclerotic cardiovascular disease (eASCVD) or high/very high ASCVD risk, defined by the 2021 European Society of Cardiology Guidelines, in seven countries in the Middle East and Africa (PACT‐MEA; NCT05317845), and to assess physicians' attitudes and the basis for their decision‐making in the management of these patients. Materials and Methods PACT‐MEA is a cross‐sectional, observational study undertaken in Bahrain, Egypt, Jordan, Kuwait, Qatar, South Africa and the United Arab Emirates based on a medical chart review of approximately 3700 patients with T2D in primary and secondary care settings, and a survey of approximately 400 physicians treating patients with T2D.

Results

The primary and secondary objectives are to determine the prevalence of eASCVD and high/very high ASCVD risk in patients with T2D. Current treatment with cardioprotective antidiabetic medication, the proportion of patients meeting the treatment criteria for reimbursement in the study countries where there is an applicable reimbursement guideline, and physician‐reported factors in clinical decision‐making in T2D management, will also be assessed.

Conclusions

This large cross‐sectional study will establish the estimated prevalence and management of eASCVD and high/very high ASCVD risk in patients with type 2 diabetes across the Middle East and Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesAtherosclerosisHumansCross-Sectional StudiesPrevalenceMiddle EastAfricaRisk Factors

Stichwörter der Autor:innen

AfricaMiddle Eastatherosclerosiscardiovascular diseasesdiabetes complicationsepidemiologyprevalencetype 2 diabetes

Autor:innen und Institutionen

  • St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Heart, Vascular & Thoracic Institute at Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
  • Royal College of Surgeons in Ireland-Bahrain, King Hamad University Hospital, Adliya, Bahrain.
  • Department of Endocrinology, Dubai Hospital, Dubai Health Authority (DHA), Dubai, United Arab Emirates.
  • Department of Pediatrics, Farwaniya Hospital, Kuwait City, Kuwait.
  • Department of Population Health, Dasman Diabetes Institute, Kuwait City, Kuwait.

ORCID-Profile: Rayaz A Malik

Förderung

  • Novo Nordisk

Zitieren

APA

Verma, S., Sabbour, H., Alamuddin, N., Alawadi, F., Alkandari, H., Almahmeed, W., Assaad-Khalil, S. H., Haddad, J., Lombard, L., Malik, R. A., Mashaki Ceyhan, E., Prasad, P., Tombak, G., & Salek, S. (2023). A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa ( PACT‐MEA ): Study design and rationale. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15011

Vancouver

Verma S, Sabbour H, Alamuddin N, Alawadi F, Alkandari H, Almahmeed W, et al. A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa ( PACT‐MEA ): Study design and rationale. Diabetes, Obesity and Metabolism. 2023. doi:10.1111/dom.15011

BibTeX
@article{Verma2023,
  author = {Verma, Subodh and Sabbour, Hani and Alamuddin, Naji and Alawadi, Fatheya and Alkandari, Hessa and Almahmeed, Wael and Assaad-Khalil, Samir H and Haddad, Jihad and Lombard, Landman and Malik, Rayaz A and Mashaki Ceyhan, Emel and Prasad, Preethy and Tombak, Gamze and Salek, Sam},
  title = {A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa ( PACT‐MEA ): Study design and rationale},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2023},
  doi = {10.1111/dom.15011}
}
Kostenlos starten →